Asylum seekers’ perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands

English version

Autoři: Christina Louka ^aff001; Elizabeth Chandler ^aff001; Adelita V. Ranchor ^aff003; Hans Broer ^aff004; Spyros Pournaras ^aff005; Sofanne J. Ravensbergen ^aff001; Ymkje Stienstra ^aff001
Působiště autorů: Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands ^aff001; ESCMID study group for infections in travelers and migrants, Basel, Switzerland ^aff002; Department of Health Psychology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands ^aff003; Vluchtelingenwerk, Netherlands ^aff004; Laboratory of Clinical Microbiology, ‘ATTIKON’ University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece ^aff005
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pone.0226948

Souhrn

Introduction

Europe has been dealing with an increasing number of refugees during the past 5 years. The timing of screening and vaccination of refugees is debated by many professionals, however refugees’ perspectives on health issues are infrequently taken into account. In this study, we aimed to investigate asylum seekers’ perspectives on infectious diseases screening and vaccination policies.

Materials and methods

Interviews were conducted in Greece and the Netherlands. Asylum seekers and recently arrived refugees were approached and informed with the help of interpreters; consent forms were acquired. The survey focused on demographic data, vaccination status, screening policies and prevention of infectious diseases.

Results

A total of 61 (43 male, 70.5%) refugees (30 Afghanis, 16 Syrian, 7 Erithrean) were interviewed. Mean age was 35.2 years (SD 13.5) and 50% had received primary or secondary education, while 24.6% received none. Median time after arrival in Greece and the Netherlands was 24 months (IQR 8.5–28). 44 out of 61 (72.1) participants were willing to be vaccinated after arrival in Europe, 26 preferred vaccination and screening to be performed at the point of entry. The need for screening and vaccination was perceived higher amongst participants in Greece (100% vs 43.3%) due to living conditions leading to increased risk of outbreaks.

Conclusion

Participants were willing to communicate their perspectives and concerns. Screening and vaccination programs could be more effective when implemented shortly after arrival and by involving asylum seekers and refugees when developing screening and vaccination interventions.

Klíčová slova:

Europe – Infectious diseases – Vaccination and immunization – Screening guidelines – Health screening – Netherlands – Greece – Scabies

Zdroje

1. Asieltrends | Immigratie- en Naturalisatiedienst (IND). [cited 2018 Nov 29]. Available from: https://ind.nl/over-ind/Cijfers-publicaties/Paginas/Asieltrends.aspx

2. UNHCR. Mediterranean Situation. Operational Portal: Refugee Situations. 2017 [cited 2018 Nov 29]. Available from: http://data2.unhcr.org/en/situations/mediterranean/location/5179

3. Beeres DT, Cornish D, Vonk M, Ravensbergen SJ, Maeckelberghe ELM, Boele Van Hensbroek P, et al. Screening for infectious diseases of asylum seekers upon arrival: The necessity of the moral principle of reciprocity. BMC Med Ethics. 2018 Mar 2;19(1):16. doi: 10.1186/s12910-018-0256-7 29499693

4. Kärki T, Napoli C, Riccardo F, Fabiani M, Grazia Dente M, Carballo M, et al. Screening for Infectious Diseases among Newly Arrived Migrants in EU/EEA Countries—Varying Practices but Consensus on the Utility of Screening. Int J Environ Res Public Health. 2014 Oct 21;11(10):11004–14. doi: 10.3390/ijerph111011004 25337945

5. Hargreaves Sally. Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries. Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700772 30326996

6. De Vito E, Parente P, de Waure C, Poscia A, Ricciardi W. A review of evidence on equitable delivery, access and utilization of immunization services for migrants and refugees in the WHO European Region The Health Evidence Network. [cited 2018 Jul 30]; Available from: http://www.euro.who.int/__data/assets/pdf_file/0005/351644/HEN53.pdf?ua=1

7. Ravensbergen SJ, Berends M, Stienstra Y, Ott A. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. de Lencastre H, editor. PLoS One. 2017 Apr 25;12(4):e0176481. doi: 10.1371/journal.pone.0176481 eCollection 2017. 28441421

8. van der Werf MJ, Lönnroth K. Pre-entry, post-entry, or no tuberculosis screening? Vol. 14, The Lancet Infectious Diseases. 2014 Nov p. 1171–2. doi: 10.1016/S1473-3099(14)70998-3 25455973

9. Thomas D, Jarvis M, Williams A. Rethinking TB screening: Politics, practicalities and the press. Thorax 2010;65:663–665. doi: 10.1136/thx.2009.132373 20610450

10. Beeres DT, Ravensbergen SJ, Heidema A, Cornish D, Vonk M, Wijnholds LD, et al. Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: A retrospective cohort study between January 2014 –March 2016. PLoS Negl Trop Dis. 2018 May 17;12(5):e0006401. doi: 10.1371/journal.pntd.0006401 eCollection 2018 May. 29771941

11. Wilting K R, Stienstra Y, Sinha B, Braks M, Cornish D, Grundmann H. Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015. Euro Surveill. 2015;20(30):pii = 21196. doi: 10.2807/1560-7917.es2015.20.30.21196 26250069

12. Brockmann SO, Wjst S, Zelmer U, Carollo S, Schmid M, Roller G, et al. ÖGD-Initiative zur Verbesserung der Durchimpfung bei Asylsuchenden. Bundesgesundheitsblatt—Gesundheitsforsch—Gesundheitsschutz 2016 May;59(5):592–8. doi: 10.1007/s00103-016-2335-6 27072499

13. Ceccarelli G, Vita S, Riva E, Cella E, Lopalco M, Antonelli F, et al. Susceptibility to measles in migrant population: Implication for policy makers. J Travel Med. 2018 Jan 1;25(1). https://doi.org/10.1093/jtm/tax080

14. Hübschen JM, Charpentier E, Weicherding P, Muller CP. IgG antibody prevalence suggests high immunization needs in newcomers to Luxembourg, 2012. Vaccine. 2018 Feb 1;899–905. doi: 10.1016/j.vaccine.2017.12.041 29306505

15. Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, et al. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine. 2018 Mar 14;36(12):1664–1672. doi: 10.1016/j.vaccine.2018.01.079 29454516

16. De Vito E, Parente P, de Waure C, Poscia A, Ricciardi W. A review of evidence on equitable delivery, access and utilization of immunization services for migrants and refugees in the WHO European Region The Health Evidence Network. Available from: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0097602/pdf/PubMedHealth_PMH0097602.pdf

17. Bradby H, Humphris R, Newall D, Phillimore J. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Refugees and Asylum Seekers in the European Region. Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Refugees and Asylum Seekers in the European Region. WHO Regional Office for Europe; 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27536765

18. Nkulu Kalengayi FK, Hurtig A-K, Nordstrand A, Ahlm C, Ahlberg BM. Perspectives and experiences of new migrants on health screening in Sweden. BMC Health Serv Res. 2016 Jan 15;16:14. doi: 10.1186/s12913-015-1218-0 26772613

19. Nellums LB, Thompson H, Holmes A, Castro-Sánchez E, Otter JA, Norredam M, et al. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018 Jul;18(7):796–811. doi: 10.1016/S1473-3099(18)30219-6 Epub 2018 May 17. 29779917

20. Carballo M, Hargreaves S, Gudumac I, Maclean EC. Evolving migrant crisis in Europe: implications for health systems. Lancet Glob Health. 2017 Mar;5(3):e252–e253. doi: 10.1016/S2214-109X(17)30040-2 28193385

21. Zoboli F, Martinelli D, Di Stefano M, Fasano M, Prato R, Santantonio TA, et al. Correlation between knowledge on transmission and prevention of HIV/STI and proficiency in condom use among male migrants from Africa and Middle East evaluated by a Condom Use Skills score using a wooden penile model. BMC Res Notes. 2017 Jun 19;10(1):216. doi: 10.1186/s13104-017-2520-1 28629409

22. Metusela C, Ussher J, Perz J, Hawkey A, Morrow M, Narchal R, et al. “In My Culture, We Don’t Know Anything About That”: Sexual and Reproductive Health of Migrant and Refugee Women. Int J Behav Med. 2017 Dec;24(6):836–845. doi: 10.1007/s12529-017-9662-3 28620774

23. Elisabetta De Vito, Paolo Parente, Chiara de Waure, Andrea Poscia, Walter Ricciardi. HEALTH EVIDENCE NETWORK SYNTHESIS REPORT 53 A review of evidence on equitable delivery, access and utilization of immunization services for migrants and refugees in the WHO European Region. Available from: http://www.euro.who.int/__data/assets/pdf_file/0005/351644/HEN53.pdf

24. Pfeil J, Kobbe R, Trapp S, Kitz C, Hufnagel M. Recommendations for the diagnosis and prevention of infectious diseases in pediatric and adolescent refugees in Germany: Statement of the German Society of Pediatric Infectious Diseases, the Society of Tropical Pediatrics and International Child Health, and the Professional Association of Pediatricians. Internist (Berl). 2016 May;57(5):416–33. doi: 10.1007/s00108-016-0040-z 27138489